Company / Current Assets
Bicara Therapeutics Inc. Current Assets History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$502.5M
FY2024
5-year range
$231.1M / $502.5M
FY2023-FY2024
Trend
+117.5%
vs FY2023
Sector context
#115 of 213
Health Care
What the data says
At $503M, Bicara Therapeutics Inc.'s current assets ranks #115 of 213 in the Health Care sector.
Based on SEC 10-K filings.
$503M in FY2024.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 213 in Health CareTop 54% of 213This company $502.5M Sector average $2.5B
▼
-80.1% below sector average
Key checks
Key Insights
- In FY2024, current assets increased 117.5% year-over-year.
- Ranks #115 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $502.5M | +117.5% |
| FY2023 | $231.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026